Christopher Keller, MD Director of Clinical Operations Boise Kidney and Hypertension Institute RPA 2011 Annual Meeting Friday, March 18, 2011.

Slides:



Advertisements
Similar presentations
The Quality Agenda for UK nephrology Charlie Tomson President, Renal Association SpR club meeting, London, Saturday 18 th September 2010.
Advertisements

Alabama Primary Health Care Association
Cardiovascular Disease in Dialysis and Renal Transplantation
Risk Stratification in Renal Care Mary Jane McKendry Vice President, Operations Fresenius Disease Management Optimal Renal Care.
Confounding: what it is and how to deal with it Kitty J. Jager¹, Carmine Zoccali 2, Alison MacLeod 3 and Friedo W. Dekker 1,4 1 ERA–EDTA Registry, Dept.
PDA is OK ….. Public/Private Doctor Agreement in Managing TB Cases Sandra Guerra-Cantu, MD, MPH Region 8 Medical Director.
Cardiac Risk In ESRD Patient
The National Kidney Foundations Kidney Early Evaluation Program TM The National Kidney Foundations Kidney Early Evaluation Program TM Essex-Passaic Wellness.
Journal Club: AKI and timing of RRT in Post-op ITU Patients
+ Understanding Kidney Disease and Renal Dialysis Brooke Grussing Concordia College.
David Taber, Charles Bratton, Angello Lin, John McGillicuddy, Kenneth Chavin and Prabhakar Baliga.
Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of the Registry to Improve Heart Failure Therapies.
Patient Web Portals: What’s the Convenience Worth to Patients? Kenneth Adler, MD, MMM Medical Director of Information Technology Arizona Community Physicians.
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
September 23, 2014 ACCESS-Mental Health CT: Meet the Hub Teams.
A Comparison of Early Versus Late Initiation of Renal Replacement Therapy in Critically III Patients with Acute Kidney Injury: A Systematic Review and.
Lysaght, J Am Soc Nephrol, 2002 Number of patients worldwide treated with chronic dialysis from 1990 to ,000 1,490,000 2,500,000.
The PREVEND Study: Screening for micro-albuminuria
Recent Advances in Management of CRF Yousef Boobess, M.D. Head, Nephrology Division Tawam Hospital.
Namirah Jamshed M.B;B.S Associate Professor of Clinical Medicine Georgetown University School of Medicine MedStar Washington Hospital Center ©AAHCM.
Renal Replacement Therapy: What the PCP Needs to Know.
DIALYSIS OR TRANSPLANTATION Ahmed Halawa MDSC175: Transplantation Science for Transplant Clinicians (Online) POSTGRADUATE SCHOOL OF MEDICINE A MEMBER OF.
A Perspective on CKD Management Mony Fraer May 2014.
FFBI Change Concepts FFBI Change Concept #12 Presented by: Ellen DePrat, MSN, RN, NE, CPHQ Project Coordinator - HealthInsight (QIO for Nevada/Utah) October.
Remote Monitoring of Chronic Kidney Disease – Sheffield Experience Dr Arif Khwaja + Sister Sue Siddall Sheffield Kidney Institute.
Oncology and Palliative Care: Promoting the Comfort and Cure Model Parag Bharadwaj, MD FAAHPM.
Hypertension and The Kidney Update: Clinical Trials Paul J. Scheel, Jr., M.D. Director, Division of Nephrology The Johns Hopkins University School of Medicine.
Kidney Diseases Prevention. Overview The mortality rate of Nephritis, Nephrotic Syndrome, and Nephrosis (18.15 per 100,000 population) marching the 7th.
CKD Conservative care and preparation for dialysis UK Renal Registry 2013 Annual Audit Meeting Dr Anirudh Rao Registrar, UK Renal Registry.
Reference Cooper BA, and the IDEAL study group. A randomized controlled trial of early versus late initiation of dialysis. N Engl J Med [Accessed.
“Yes Minister, we can deliver cheaper kidney care” Lisa Burnapp Lead Nurse-Living Donation, NHS Blood & Transplant Consultant Nurse-Living Donor Kidney.
RENAL DISEASE IN DIABETES
Improving Primary Care Treatment of CKD David Feldstein, MD Assistant Professor Department of Medicine UW SMPH.
Health Care Costs Associated with Chronic Kidney Disease in Patients with Type II Diabetes Zita Shiue, MD Internal Medicine, R3 Chief of Medicine Conference.
Kidney Transplant: A Realistic Chance for Elderly Patients Reference: Munnapradist S, Danovitch GM. Kidney transplants for the elderly: Hope or hype? Clin.
CHRONIC KIDNEY DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Advanced CKD Study Daniel Ford UKRR Annual Audit Meeting June 2009.
Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345: , 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.
Transitioning to Palliative Care: Starting the Conversation Dr. José Pereira Head Division of Palliative Care, University of Ottawa Medical Chief, Palliative.
Section 5: Configuration of healthcare to manage CKD.
Section 3: CKD, CVD and mortality. Cardiovascular diseases in CKD patients Damage to the heart (Uraemic cardiomyopathy ) Damage to the arteries (Uraemic.
The State of the Association Opening Ceremonies April 15, 2004 Washington, DC.
B. Todd Sitzman, MD, MPH Hattiesburg, MS Building a Collaborative Program: Neurosurgeon and Pain Specialist.
Information, Quality and Values Donal O’Donoghue National Clinical Director for Kidney Care Working for better kidney care UKRR and NHS Kidney Care Information.
U.S. Department of Health and Human Services National Institute of Health Optimal Preparation for ESRD ESRD:State of the Art and Charting the Challenges.
Excessive fluid is not needed: So why is Dr. Durward so wasteful? Timothy E Bunchman MD Professor & Director Pediatric Nephrology
Selected aspects of acid base physiology- acidosis in CKD
Minority Affairs Committee Fall  Patient resource promoting early referral for transplant evaluation  Collaborated with Patient Affairs Committee.
Chronic Kidney Disease (CKD) Healthy Kansans 2010.
1 Antonio Bellasi, MD Medical manager Genzyme, Italy Chronic Kidney Disease-Mineral Bone Disorders (CKD-MBD)
John A. Kellum, MD, MCCM Professor of Critical Care Medicine, Medicine, Bioengineering and Clinical & Translational Science Vice Chair for Research Director,
Improving Ethnic/Race Disparities in ESRD by Helping Patients make Informed Decisions about Treatment L. Ebony Boulware, MD MPH Associate Professor of.
PREVALENCE, PATTERN AND OUTCOMES OF PATIENTS PRESENTING WITH RENAL DISEASES Alfred J. Meremo, MD College of Health Sciences, UDOM. 18 th March 2016.
Chronic Haemodialysis therapy in octogenarians with ESRF: demographics and outcomes from a single centre in England Dr Punit Yadav Dr Jyoti Baharani.
A Preliminary Evaluation of the KidneyWise Clinical Toolkit For Primary Care Allan Grill MD, CCFP, MPH, FCFP, CCPE Provincial Primary Care Lead, Ontario.
Preemptive Kidney Transplant (PKT) – the Optimal Therapy in ESRD Reference: Connie L. Davis. Preemptive transplantation and the transplant first initiative.
Intercepting CKD in Primary Care
World Kidney Day 2016: Kidney Disease & Children
A.M. Thompson, T.G. Pickering  Kidney International 
PeArLS (Personally Arranged Learning Session)
Lessons Learned: PCMH and Value Based Payment
Haiyan Wang, Luxia Zhang, Jicheng Lv  Kidney International 
Managing HF in Primary Care
West Midlands Clinical Network
Nowak et al. Am J Nephrol 2016;44: (DOI: / )
KidneyWise Clinical Toolkit Launched May 2015
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Targeting Immunity in End-Stage Renal Disease
Managing HF in Primary Care
Getting Started with Palliative Care
Presentation transcript:

Christopher Keller, MD Director of Clinical Operations Boise Kidney and Hypertension Institute RPA 2011 Annual Meeting Friday, March 18, 2011

Disclosure of Conflict of Interest Name of Faculty or Presenter Reported Financial Relationship Christopher Keller, MD Consulting Fees Genzyme Corporation Affymax, AMAG Study Investigator for Research Cytochroma, Fibrogen, Pfizer, Takeda, Boehringer Ingelheim, Johnson & Johnson, Abbott, Amgen, Advanced Renal Technologies

Christopher Keller, MD Director of Clinical Operations Boise Kidney and Hypertension Institute RPA 2011 Annual Meeting Friday, March 18, 2011

What are the issues? Primary care providers (PCPs) often defer referrals until very advanced stages of CKD 25-50% of all ESRD patients never saw a nephrologist until 3 months or less before onset of dialysis Reasons for not referring: advanced age, comorbidities, and perceived patient nonadherence to therapy Fischer MJ et al., Am J Nephrol 2011;33:60-69 Navaneethan et al., Clin Nephrol 2010;73:

What are the issues? Nephrologists are spending more time focused on CKD progression and less time on non-nephrology concerns The use of a multidisciplinary team (MDT) to manage stage 3-4 CKD patients may slow progression of CKD and may improve outcomes at the start of dialysis Diamantidis CJ et al., Clin J Am Soc Nephrol 2011;6: Bayliss EA et al., Clin J Am Soc Nephrol 2011;6: April Epub

Slowing CKD progression with an MDT Bayliss EA et al., Clin J Am Soc Nephrol 2011;6: April Epub

Curtis et al. Nephrol Dial Transplant 2005;20:147 Kaplan-Meyer survival after starting dialysis therapy Mortality benefit with an MDT

Open the black box… PCPs must play a critical role in the multidisciplinary team RPA ToolKit website: Diamantidis CJ et al., Clin J Am Soc Nephrol 2011;6:

How do we involve primary providers? Step 1: Identify your goals for co-management Preferences for timing of referrals Step 2: Open communication lines with primary providers Ask them directly about their co-management interests Let them know that you are willing to answer questions Tonelli M et al., Ann Intern Med 2011;154:12-21

How do we involve primary providers? Step 3: Communicate regularly with primary providers Ensure timely, effective communication with the PCPs every visit Track referrals and identify providers that do not refer early; devote resources for education Electronic record systems and note templates make it easier

Boise Kidney model: Documentation

Conclusions The complexity and breath of nephrology management has been a barrier to PCP communication Multidisciplinary care of advanced CKD patients may slow CKD progression and reduce mortality in CKD patients Communication with PCPs is required to: Optimize early referrals Permit nephrologists more time and energy to focus on prevention of ESRD